Edition:
United States

EyeGate Pharmaceuticals Inc (EYEG.OQ)

EYEG.OQ on NASDAQ Stock Exchange Capital Market

0.60USD
2:21pm EST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.60
Open
$0.59
Day's High
$0.61
Day's Low
$0.59
Volume
2,560
Avg. Vol
48,069
52-wk High
$3.15
52-wk Low
$0.54

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.07 -0.241
Jun '17 0.15 -0.276
Mar '17 0.18 -0.279
FY 2016 Dec '16 0.16 -0.376
Sep '16 0.27 -0.364
Jun '16 0.23 -0.457
Mar '16 0.00 -0.311
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-18 1 -0.24 -0.24 -0.24 --
Quarter Ending Jun-18 1 -0.20 -0.20 -0.20 --
Year Ending Dec-18 1 -0.65 -0.65 -0.65 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.98 34.59
P/E High - Last 5 Yrs. -- 40.44 45.93
P/E Low - Last 5 Yrs. -- 23.35 24.19
Beta -- 0.82 0.81
Price to Sales (TTM) 18.12 5.68 8.08
Price to Book (MRQ) 15.14 4.36 5.24
Price to Tangible Book (MRQ) -- 4.90 6.43
Price to Cash Flow (TTM) -- 22.95 25.98
% Owned Institutions 34.06 1.24 2.27

Dividends

  Company industry sector
Dividend Yield -- 1.60 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.22 5.21
Payout Ratio(TTM) -- 43.76 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -72.77 8.49 9.76
Sales (TTM) vs TTM 1 Yr. Ago 11.59 6.41 7.61
Sales - 5 Yr. Growth Rate -- 9.87 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 33.94 16.81 18.78
EPS (TTM) vs TTM 1 Yr. Ago 20.97 -- --
EPS - 5 Yr. Growth Rate -- 10.44 11.55
Capital Spending - 5 Yr. Growth Rate -- 14.57 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.40 2.42
Current Ratio (MRQ) 0.81 3.34 3.39
LT Debt to Equity (MRQ) 0.97 9.39 12.18
Total Debt to Equity (MRQ) 0.97 12.62 15.60
Interest Coverage (TTM) -1,163.53 44.43 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.20 54.74
Gross Margin - 5 Yr. Avg. -- 52.46 52.50
EBITD Margin (TTM) -2,477.49 -- --
EBITD - 5 Yr. Avg -- 18.43 14.67
Operating Margin (TTM) -2,480.68 11.85 4.40
Operating Margin - 5 Yr. Avg. -- 14.25 9.99
Pre-Tax Margin (TTM) -2,480.75 12.22 5.14
Pre-Tax Margin - 5 Yr. Avg. -- 14.51 10.24
Net Profit Margin (TTM) -2,480.75 8.65 1.86
Net Profit Margin - 5 Yr. Avg. -- 10.86 6.55
Effective Tax Rate (TTM) -- 22.18 21.87
Effective Tax Rate - 5 Yr. Avg. -- 23.50 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 924,143,029 823,803,020
Net Income/Employee (TTM) -- 108,124,219 96,327,335
Receivable Turnover (TTM) 1.68 5.35 5.44
Inventory Turnover (TTM) -- 2.62 3.52
Asset Turnover (TTM) 0.04 0.93 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -105.62 11.21 10.76
Return on Assets - 5 Yr. Avg. -- 12.69 12.05
Return on Investment (TTM) -422.60 14.12 13.67
Return on Investment - 5 Yr. Avg. -- 16.62 15.78
Return on Equity (TTM) -717.89 15.72 15.40
Return on Equity - 5 Yr. Avg. -- 17.74 17.04
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 43.96 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for EyeGate Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.46%
# of Holders: 23
Total Shares Held: 5,584,299
3 Mo. Net Change: -522,367
# New Positions: 6
# Closed Positions: 2
# Increased Positions: 9
# Reduced Positions: 7
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.